首页> 美国卫生研究院文献>British Medical Journal >Brain Amine Concentrations after Monoamine Oxidase Inhibitor Administration
【2h】

Brain Amine Concentrations after Monoamine Oxidase Inhibitor Administration

机译:单胺氧化酶抑制剂给药后脑中胺浓度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The concentrations of 5-hydroxytryptamine (5HT), noradrenaline, and dopamine were estimated post mortem in brain stem, hypothalamus, and caudate nucleus in 33 patients who had been treated with isocarboxazid, clorgyline, or tranylcypromine and 11 controls. Similar and highly significant increases in 5HT and noradrenaline concentration occurred with all three drugs. The distribution was unimodal, but about a quarter of the patients showed only a small increase in brain amines. Tranylcypromine seemed to have a significantly greater effect on dopamine in caudate nucleus and hypothalamus compared with isocarboxazid and clorgyline. In the doses used chlorpromazine did not reduce the amine concentrations. Four patients with Parkinson's syndrome had low concentrations of dopamine in caudate nucleus in spite of monoamine oxidase inhibitor administration.
机译:估计33例接受异卡波肼,氯吉林或tranylcypromine治疗的患者的脑干,下丘脑和尾状核中5-羟色胺(5HT),去甲肾上腺素和多巴胺的浓度。所有这三种药物的5HT和去甲肾上腺素浓度均出现相似且高度显着的增加。分布是单峰的,但是大约四分之一的患者脑胺仅少量增加。与异羧甲胺和氯氰菊酯相比,三苯甲基丙胺对尾状核和下丘脑中的多巴胺似乎有更大的影响。在所用剂量中,氯丙嗪不会降低胺的浓度。尽管使用了单胺氧化酶抑制剂,但仍有四名帕金森综合症患者的尾状核中多巴胺浓度较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号